Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-07 Sale |
2024-11-12 4:09 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
20,000 | $55.86 | $1,117,147 | 53,886 (Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 8:36 pm |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
10,420 | $28.17 | $293,557 | 104,091 (Direct) |
View |
| 2024-04-10 Sale |
2024-04-12 6:23 pm |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
67,000 | $23.36 | $1,564,812 | 146,903 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 8:40 pm |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,485 | $19.15 | $66,729 | 84,761 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 9:32 pm |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,237 | $19.08 | $61,758 | 104,674 (Direct) |
View |
| 2024-03-20 Sale |
2024-03-22 7:46 pm |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
13,278 | $19.16 | $254,462 | 41,912 (Direct) |
View |
| 2023-02-22 Sale |
2023-02-22 8:25 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
32,861 | $4.66 | $153,132 | 87,835 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 6:24 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
11,313 | $3.91 | $44,234 | 120,696 (Direct) |
View |
| 2020-12-17 Sale |
2020-12-21 4:47 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
4,999 | $25 | $124,975 | 263,999 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 4:15 pm |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
1 | $25 | $25 | 268,998 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:33 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
20,491 | $0 | 20,491 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-12 4:09 pm |
N/A 2032-08-11 |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
20,000 | $0 | 53,886 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-12 4:09 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
20,000 | $25.99 | 53,886 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 8:36 pm |
N/A 2029-05-16 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
10,420 | $0 | 104,091 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 8:36 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
6,314 | $19.68 | 104,091 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-10 8:36 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
4,106 | $5.52 | 104,091 (Direct) |
View |
| 2024-08-11 Exercise |
2024-08-13 4:15 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
2,302 | $0 | 10,294 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
13,894 | $0 | 13,894 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-17 5:22 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
3,388 | $0 | 5,690 (Direct) |
View |
| 2024-04-10 Exercise |
2024-04-12 6:23 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
62,420 | $12.6 | 146,903 (Direct) |
View |
| 2024-04-10 Exercise |
2024-04-12 6:23 pm |
N/A 2028-10-19 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
67,000 | $0 | 146,903 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-12 6:23 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
4,580 | $19.68 | 146,903 (Direct) |
View |
| 2024-04-04 Exercise |
2024-04-08 8:40 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,485 | $12.6 | 84,761 (Direct) |
View |
| 2024-04-04 Exercise |
2024-04-08 8:40 pm |
N/A 2028-10-19 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,485 | $0 | 84,761 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 9:32 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
94 | $12.6 | 104,674 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 9:32 pm |
N/A 2028-10-19 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,237 | $0 | 104,674 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 9:32 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
3,143 | $5.52 | 104,674 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 7:46 pm |
N/A 2032-01-27 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
13,278 | $0 | 41,912 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 7:46 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
13,278 | $5.52 | 41,912 (Direct) |
View |
| 2024-02-13 Option Award(A) |
2024-02-20 7:24 pm |
N/A 2034-02-13 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
23,364 | $0 | 23,364 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:41 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
16,835 | $0 | 16,835 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-15 4:06 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
2,302 | $0 | 6,906 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:25 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
22,346 | $0 | 22,346 (Direct) |
View |
| 2023-02-23 Option Award |
2023-04-06 8:15 pm |
N/A 2033-02-23 |
Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director |
27,567 | $0 | 27,567 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 6:31 pm |
N/A 2032-08-11 |
AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director |
44,853 | $0 | 44,853 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 5:02 pm |
N/A 2032-01-27 |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
131,400 | $0 | 268,409 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 4:44 pm |
N/A 2031-01-27 |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
133,350 | $0 | 133,959 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-21 4:47 pm |
N/A 2028-10-18 |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
4,999 | $0 | 263,999 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-21 4:47 pm |
N/A N/A |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
4,999 | $3.15 | 263,999 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:15 pm |
N/A 2028-10-18 |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
1 | $0 | 268,998 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 4:15 pm |
N/A N/A |
IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer |
1 | $3.15 | 268,998 (Direct) |
View |